Globus Medical Long-Term Investments 2010-2025 | GMED
Globus Medical long-term investments from 2010 to 2025. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
- Globus Medical long-term investments for the quarter ending March 31, 2025 were $0M, a 100% decline year-over-year.
- Globus Medical long-term investments for 2024 were $0.066B, a 12.32% decline from 2023.
- Globus Medical long-term investments for 2023 were $0.075B, a 84.79% decline from 2022.
- Globus Medical long-term investments for 2022 were $0.496B, a 11.84% decline from 2021.
| Globus Medical Annual Long-Term Investments (Millions of US $) |
|
|---|---|
| 2024 | $66 |
| 2023 | $75 |
| 2022 | $496 |
| 2021 | $562 |
| 2020 | $359 |
| 2019 | $410 |
| 2018 | $263 |
| 2017 | $56 |
| 2016 | $60 |
| 2015 | $49 |
| 2014 | $75 |
| 2013 | $37 |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $0 |
| 2009 | $0 |
| Globus Medical Quarterly Long-Term Investments (Millions of US $) |
|
|---|---|
| 2025-03-31 | |
| 2024-12-31 | $66 |
| 2024-09-30 | $12 |
| 2024-06-30 | $28 |
| 2024-03-31 | $51 |
| 2023-12-31 | $75 |
| 2023-09-30 | $276 |
| 2023-06-30 | $392 |
| 2023-03-31 | $480 |
| 2022-12-31 | $496 |
| 2022-09-30 | $504 |
| 2022-06-30 | $474 |
| 2022-03-31 | $547 |
| 2021-12-31 | $562 |
| 2021-09-30 | $432 |
| 2021-06-30 | $454 |
| 2021-03-31 | $435 |
| 2020-12-31 | $359 |
| 2020-09-30 | $276 |
| 2020-06-30 | $319 |
| 2020-03-31 | $380 |
| 2019-12-31 | $410 |
| 2019-09-30 | $383 |
| 2019-06-30 | $370 |
| 2019-03-31 | $301 |
| 2018-12-31 | $263 |
| 2018-09-30 | $169 |
| 2018-06-30 | $156 |
| 2018-03-31 | $104 |
| 2017-12-31 | $56 |
| 2017-09-30 | $59 |
| 2017-06-30 | $61 |
| 2017-03-31 | $63 |
| 2016-12-31 | $60 |
| 2016-09-30 | $64 |
| 2016-06-30 | $66 |
| 2016-03-31 | $59 |
| 2015-12-31 | $49 |
| 2015-09-30 | $62 |
| 2015-06-30 | $81 |
| 2015-03-31 | $72 |
| 2014-12-31 | $75 |
| 2014-09-30 | $47 |
| 2014-06-30 | $37 |
| 2014-03-31 | $24 |
| 2013-12-31 | $37 |
| 2013-09-30 | $51 |
| 2013-06-30 | $71 |
| 2013-03-31 | $62 |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2011-09-30 | |
| 2011-06-30 | |
| 2011-03-31 | |
| 2010-12-31 | |
| 2009-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.351B | $2.519B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $183.069B | 22.15 |
| Intuitive Surgical (ISRG) | United States | $177.069B | 73.39 |
| Edwards Lifesciences (EW) | United States | $46.042B | 30.54 |
| IDEXX Laboratories (IDXX) | United States | $45.559B | 52.36 |
| Alcon (ALC) | Switzerland | $44.466B | 30.05 |
| DexCom (DXCM) | United States | $35.105B | 54.26 |
| IQVIA Holdings (IQV) | United States | $33.619B | 19.00 |
| Mettler-Toledo (MTD) | United States | $26.208B | 31.17 |
| STERIS (STE) | Ireland | $22.284B | 24.54 |
| Waters (WAT) | United States | $17.993B | 25.39 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.253B | 0.00 |
| Hologic (HOLX) | United States | $14.639B | 15.91 |
| Sysmex ADR (SSMXY) | Japan | $10.588B | 30.04 |
| Penumbra (PEN) | United States | $8.914B | 69.96 |
| Masimo (MASI) | United States | $8.793B | 32.44 |
| Glaukos (GKOS) | United States | $5.424B | 0.00 |
| Teleflex (TFX) | United States | $5.106B | 8.43 |
| Integer Holdings (ITGR) | United States | $3.789B | 18.91 |
| TransMedics (TMDX) | United States | $3.560B | 77.38 |
| PROCEPT BioRobotics (PRCT) | United States | $2.992B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.370B | 14.11 |
| Veracyte (VCYT) | United States | $1.959B | 27.50 |
| Elekta AB (EKTAY) | Sweden | $1.933B | 17.38 |
| Nihon Kohden (NHNKY) | Japan | $1.911B | 21.92 |
| Alphatec Holdings (ATEC) | United States | $1.636B | 0.00 |
| Artivion (AORT) | United States | $1.337B | 125.24 |
| Tandem Diabetes Care (TNDM) | United States | $1.122B | 0.00 |
| OPKO Health (OPK) | United States | $1.071B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.023B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.018B | 5.41 |
| SiBone (SIBN) | United States | $0.750B | 0.00 |
| IRadimed (IRMD) | United States | $0.726B | 36.85 |
| Beta Bionics (BBNX) | United States | $0.607B | 0.00 |
| AxoGen (AXGN) | United States | $0.592B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.555B | 8.64 |
| OrthoPediatrics (KIDS) | United States | $0.544B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.541B | 11.65 |
| Pacific Biosciences Of California (PACB) | United States | $0.492B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.447B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.425B | 9.88 |
| Delcath Systems (DCTH) | United States | $0.397B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.371B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.362B | 0.00 |
| RxSight (RXST) | United States | $0.320B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.307B | 0.00 |
| Neuronetics (STIM) | United States | $0.299B | 0.00 |
| NeuroPace (NPCE) | United States | $0.287B | 0.00 |
| 908 Devices (MASS) | United States | $0.263B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.254B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.245B | 14.82 |
| CVRx (CVRX) | United States | $0.220B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.203B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.183B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.182B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Accuray (ARAY) | United States | $0.143B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.125B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.121B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.118B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.106B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 53.20 |
| Hyperfine (HYPR) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| Spectral AI (MDAI) | United States | $0.070B | 0.00 |
| Positron (POSC) | United States | $0.061B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.058B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.057B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 20.78 |
| WORK Medical Technology Group (WOK) | China | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 14.76 |